Satellos Accumulated Other Comprehensive Income from 2010 to 2026

MSCL Stock   0.89  0.05  5.32%   
Satellos Bioscience Accumulated Other Comprehensive Income yearly trend continues to be very stable with very little volatility. Accumulated Other Comprehensive Income is likely to grow to about -237.1 K this year. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
2010-12-31
Previous Quarter
-249.6 K
Current Value
-237.1 K
Quarterly Volatility
5.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Satellos Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Satellos Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Selling General Administrative of 9.9 M or Selling And Marketing Expenses of 338.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.81. Satellos financial statements analysis is a perfect complement when working with Satellos Bioscience Valuation or Volatility modules.
  
This module can also supplement various Satellos Bioscience Technical models . Check out the analysis of Satellos Bioscience Correlation against competitors.

Latest Satellos Bioscience's Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of Satellos Bioscience over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Satellos Bioscience's Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Satellos Bioscience's overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Pretty Stable
   Accumulated Other Comprehensive Income   
       Timeline  

Satellos Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean1,206,650
Geometric Mean6,840
Coefficient Of Variation427.92
Mean Deviation2,356,982
Median(1,444)
Standard Deviation5,163,536
Sample Variance26.7T
Range21.5M
R-Value0.24
Mean Square Error26.8T
R-Squared0.06
Significance0.35
Slope248,223
Total Sum of Squares426.6T

Satellos Accumulated Other Comprehensive Income History

2026-237.1 K
2025-249.6 K
2024-217 K
202321.2 M
2022 -7000.0

About Satellos Bioscience Financial Statements

Satellos Bioscience investors utilize fundamental indicators, such as Accumulated Other Comprehensive Income, to predict how Satellos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-249.6 K-237.1 K

Pair Trading with Satellos Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Satellos Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satellos Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Satellos Stock

  0.45BRK Berkshire Hathaway CDRPairCorr
  0.45BRK Berkshire Hathaway CDRPairCorr
The ability to find closely correlated positions to Satellos Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Satellos Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Satellos Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Satellos Bioscience to buy it.
The correlation of Satellos Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Satellos Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Satellos Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Satellos Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Satellos Stock

Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.